Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Polycystic Ovary Syndrome 2Pituitary Neoplasms 2Urinary Bladder Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Sezary Syndrome 1Sarcoma 1Prostatic Neoplasms 1Pituitary ACTH Hypersecretion 1Pancreatic Neoplasms 1Obesity 1Mycosis Fungoides 1Melanoma 1Lymphoma, T-Cell, Cutaneous 1Liposarcoma 1Diabetes Mellitus, Type 2 1Central Nervous System Neoplasms 1Carcinoma, Hepatocellular 1Breast Neoplasms 1Adenocarcinoma Of Esophagus 1

Interventions

Metformin 139Clomiphene 44Letrozole 36Inositol 27Folic Acid 17Exercise 17Progesterone 16Ethinyl Estradiol 13Caloric Restriction 13drospirenone and ethinyl estradiol combination 12Estradiol 12Contraceptives, Oral 11cetrorelix 10Pioglitazone 10High-Intensity Interval Training 10Chorionic Gonadotropin 10Triptorelin Pamoate 9Tablets 9Spironolactone 8Diet 8Cholecalciferol 8Vitamin D 7Thioctic Acid 7Surveys and Questionnaires 7Menotropins 7Liraglutide 7Gonadotropins 7Acupuncture Therapy 7drospirenone 6Ovidrel 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Polycystic Ovary Syndrome × Rosiglitazone × Clear all
NCT01019356 2022-01-20

Role of Insulin Action and Free Fatty Acids in Hyperandrogenism of Women With Polycystic Ovary Syndrome

Université de Sherbrooke

Phase NA Completed
52 enrolled

Polycystic Ovary Syndrome

NCT00640224 2017-11-17

Insulin Resistance, Polycystic Ovary Syndrome, and Bone Research Study

University of Pittsburgh

Phase 4 Completed
65 enrolled 28 charts

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡